$2.95 Billion is the total value of Boxer Capital, LLC's 85 reported holdings in Q1 2021. The portfolio turnover from Q4 2020 to Q1 2021 was 32.1% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| MRTX | Buy | MIRATI THERAPEUTICS INC | $342,600,000 | -11.7% | 2,000,000 | +13.3% | 11.62% | -6.8% |
| BGNE | Sell | BEIGENE LTDsponsored adr | $265,999,000 | -7.6% | 764,188 | -31.4% | 9.02% | -2.5% |
| RVMD | Buy | REVOLUTION MEDICINES INC | $159,858,000 | +22.0% | 3,484,264 | +5.3% | 5.42% | +28.7% |
| SWTX | SPRINGWORKS THERAPEUTICS INC | $152,724,000 | +1.4% | 2,075,905 | 0.0% | 5.18% | +7.0% | |
| ITOS | ITEOS THERAPEUTICS INC | $148,513,000 | +1.1% | 4,345,016 | 0.0% | 5.04% | +6.6% | |
| SAGE | SAGE THERAPEUTICS INC | $81,886,000 | -13.5% | 1,094,000 | 0.0% | 2.78% | -8.7% | |
| PMVP | PMV PHARMACEUTICALS INC | $74,602,000 | -46.5% | 2,268,236 | 0.0% | 2.53% | -43.6% | |
| SBTX | SILVERBACK THERAPEUTICS INC | $73,097,000 | -5.8% | 1,675,377 | 0.0% | 2.48% | -0.7% | |
| RCKT | ROCKET PHARMACEUTICALS INC | $65,049,000 | -19.1% | 1,466,051 | 0.0% | 2.21% | -14.6% | |
| RCUS | ARCUS BIOSCIENCES INC | $58,544,000 | +8.2% | 2,084,883 | 0.0% | 1.98% | +14.1% | |
| SGEN | New | SEAGEN INC | $55,544,000 | – | 400,000 | +100.0% | 1.88% | – |
| IDYA | IDEAYA BIOSCIENCES INC | $51,766,000 | +67.9% | 2,202,812 | 0.0% | 1.76% | +77.2% | |
| SNDX | SYNDAX PHARMACEUTICALS INC | $51,155,000 | +0.5% | 2,287,782 | 0.0% | 1.74% | +6.1% | |
| BDTX | BLACK DIAMOND THERAPEUTICS I | $48,880,000 | -24.3% | 2,014,858 | 0.0% | 1.66% | -20.1% | |
| CYTK | CYTOKINETICS INC | $48,846,000 | +11.9% | 2,100,000 | 0.0% | 1.66% | +18.1% | |
| ARGX | ARGENX SEsponsored adr | $47,071,000 | -6.4% | 170,926 | 0.0% | 1.60% | -1.2% | |
| NUVB | New | NUVATION BIO INC | $45,364,000 | – | 4,341,009 | +100.0% | 1.54% | – |
| CGEM | New | CULLINAN ONCOLOGY INC | $44,757,000 | – | 1,074,082 | +100.0% | 1.52% | – |
| RLAY | RELAY THERAPEUTICS INC | $44,738,000 | -16.8% | 1,294,132 | 0.0% | 1.52% | -12.3% | |
| DBVT | DBV TECHNOLOGIES S Asponsored adr | $40,159,000 | +208.1% | 7,534,598 | 0.0% | 1.36% | +225.1% | |
| MRUS | Buy | MERUS N V | $39,691,000 | +58.6% | 1,900,000 | +33.1% | 1.35% | +67.2% |
| CNTB | New | CONNECT BIOPHARMA HLDS LTDads | $38,504,000 | – | 2,081,323 | +100.0% | 1.31% | – |
| NRIX | NURIX THERAPEUTICS INC | $38,082,000 | -5.4% | 1,224,892 | 0.0% | 1.29% | -0.2% | |
| AMRN | AMARIN CORP PLCspons adr new | $37,260,000 | +27.0% | 6,000,000 | 0.0% | 1.26% | +34.0% | |
| MARINUS PHARMACEUTICALS INC | $37,152,000 | +26.9% | 2,400,000 | 0.0% | 1.26% | +33.9% | ||
| BCAB | BIOATLA INC | $34,894,000 | +49.5% | 686,347 | 0.0% | 1.18% | +57.7% | |
| ALGS | ALIGOS THERAPEUTICS INC | $34,702,000 | -17.8% | 1,526,048 | 0.0% | 1.18% | -13.2% | |
| BCEL | ATRECA INC | $33,762,000 | -5.1% | 2,202,333 | 0.0% | 1.14% | +0.2% | |
| PASG | PASSAGE BIO INC | $33,707,000 | -31.6% | 1,928,315 | 0.0% | 1.14% | -27.9% | |
| KNTE | Buy | KINNATE BIOPHARMA INC | $33,215,000 | -21.6% | 1,065,939 | +0.1% | 1.13% | -17.3% |
| KURA | KURA ONCOLOGY INC | $29,692,000 | -13.4% | 1,050,289 | 0.0% | 1.01% | -8.7% | |
| ANAB | ANAPTYSBIO INC | $28,015,000 | +0.2% | 1,300,000 | 0.0% | 0.95% | +5.8% | |
| LABD | Sell | DIREXION SHS ETF TRdaily s&p biotec | $27,175,000 | -52.2% | 1,250,000 | -44.4% | 0.92% | -49.6% |
| ACHL | New | ACHILLES THERAPEUTICS PLCsponsored ads | $25,424,000 | – | 1,536,208 | +100.0% | 0.86% | – |
| RNA | AVIDITY BIOSCIENCES INC | $24,456,000 | -14.5% | 1,121,327 | 0.0% | 0.83% | -9.9% | |
| KDMN | KADMON HLDGS INC | $24,141,000 | -6.3% | 6,205,882 | 0.0% | 0.82% | -1.1% | |
| AKRO | AKERO THERAPEUTICS INC | $24,122,000 | +12.4% | 831,495 | 0.0% | 0.82% | +18.6% | |
| GOSS | GOSSAMER BIO INC | $23,702,000 | -4.3% | 2,562,358 | 0.0% | 0.80% | +1.0% | |
| SLDB | SOLID BIOSCIENCES INC | $23,417,000 | -27.0% | 4,234,574 | 0.0% | 0.79% | -23.1% | |
| FOLD | AMICUS THERAPEUTICS INC | $22,971,000 | -57.2% | 2,325,000 | 0.0% | 0.78% | -54.9% | |
| MREO | MEREO BIOPHARMA GROUP PLCads | $20,984,000 | -5.9% | 6,226,673 | 0.0% | 0.71% | -0.7% | |
| EPIX | New | ESSA PHARMA INC | $19,957,000 | – | 687,000 | +100.0% | 0.68% | – |
| TLIS | New | TALIS BIOMEDICAL CORP | $19,930,000 | – | 1,550,998 | +100.0% | 0.68% | – |
| ODT | ODONATE THERAPEUTICS INC | $19,176,000 | -82.2% | 5,607,086 | 0.0% | 0.65% | -81.2% | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | $18,878,000 | -13.9% | 250,000 | 0.0% | 0.64% | -9.2% | |
| NLTX | NEOLEUKIN THERAPEUTICS INC | $18,478,000 | -12.7% | 1,501,058 | 0.0% | 0.63% | -7.8% | |
| CBAY | CYMABAY THERAPEUTICS INC | $18,160,000 | -20.9% | 4,000,000 | 0.0% | 0.62% | -16.5% | |
| CABA | CABALETTA BIO INC | $17,797,000 | -11.1% | 1,603,361 | 0.0% | 0.60% | -6.1% | |
| GMTX | New | GEMINI THERAPEUTICS INC | $17,615,000 | – | 1,300,000 | +100.0% | 0.60% | – |
| IMVT | New | IMMUNOVANT INC | $16,040,000 | – | 1,000,000 | +100.0% | 0.54% | – |
| RACA | THERAPEUTICS ACQUISITION COR | $15,765,000 | -24.5% | 1,500,000 | 0.0% | 0.54% | -20.3% | |
| CDAK | Buy | CODIAK BIOSCIENCES INC | $15,533,000 | -20.2% | 1,030,065 | +70.9% | 0.53% | -15.8% |
| MIST | Buy | MILESTONE PHARMACEUTICALS IN | $14,893,000 | -10.3% | 2,572,194 | +3.8% | 0.50% | -5.4% |
| SELB | SELECTA BIOSCIENCES INC | $14,860,000 | +49.3% | 3,284,072 | 0.0% | 0.50% | +57.5% | |
| ESPR | ESPERION THERAPEUTICS INC NE | $14,025,000 | +7.9% | 500,000 | 0.0% | 0.48% | +13.9% | |
| MTNB | MATINAS BIOPHARMA HLDGS INC | $12,053,000 | -22.8% | 11,478,634 | 0.0% | 0.41% | -18.5% | |
| PSTX | POSEIDA THERAPEUTICS INC | $11,948,000 | -12.9% | 1,251,055 | 0.0% | 0.40% | -8.2% | |
| BLU | BELLUS HEALTH INC NEW | $11,424,000 | +25.5% | 2,975,000 | 0.0% | 0.39% | +32.1% | |
| AGEN | AGENUS INC | $10,880,000 | -14.5% | 4,000,000 | 0.0% | 0.37% | -9.8% | |
| ARYD | New | ARYA SCIENCES ACQUISTION COcl a | $10,335,000 | – | 750,000 | +100.0% | 0.35% | – |
| MEIP | MEI PHARMA INC | $9,992,000 | +29.9% | 2,913,091 | 0.0% | 0.34% | +37.2% | |
| CERE | CEREVEL THERAPEUTICS HLDNG I | $9,810,000 | -17.2% | 714,500 | 0.0% | 0.33% | -12.6% | |
| QURE | UNIQURE NV | $8,423,000 | -6.8% | 250,000 | 0.0% | 0.29% | -1.4% | |
| VINCU | New | VINCERX PHARMA INCunit 12/24/2025 | $8,100,000 | – | 300,000 | +100.0% | 0.28% | – |
| ASMB | ASSEMBLY BIOSCIENCES INC | $6,900,000 | -24.0% | 1,500,000 | 0.0% | 0.23% | -19.9% | |
| MIRM | MIRUM PHARMACEUTICALS INC | $6,283,000 | +13.5% | 317,000 | 0.0% | 0.21% | +19.7% | |
| IMMP | New | IMMUTEP LTDsponsored ads | $6,140,000 | – | 2,000,000 | +100.0% | 0.21% | – |
| KNSA | KINIKSA PHARMACEUTICALS LTD | $5,379,000 | +4.8% | 290,577 | 0.0% | 0.18% | +10.3% | |
| BLSA | BCLS ACQUISITION CORP | $5,285,000 | -12.0% | 500,000 | 0.0% | 0.18% | -7.3% | |
| RACB | New | RESEARCH ALLIANCE CORP II | $5,125,000 | – | 500,000 | +100.0% | 0.17% | – |
| JYAC | JIYA ACQUISITION CORP | $4,920,000 | -4.5% | 500,000 | 0.0% | 0.17% | +0.6% | |
| ORIC | ORIC PHARMACEUTICALS INC | $4,900,000 | -27.6% | 200,000 | 0.0% | 0.17% | -23.9% | |
| HSAQ | HEALTH SCIENCES ACQ CORP 2 | $4,476,000 | -12.6% | 400,000 | 0.0% | 0.15% | -7.9% | |
| AGLE | AEGLEA BIOTHERAPEUTICS INC | $4,356,000 | +0.6% | 550,000 | 0.0% | 0.15% | +6.5% | |
| HLXA | HELIX ACQUISITION CORP | $4,080,000 | -10.3% | 400,000 | 0.0% | 0.14% | -5.5% | |
| LJPC | LA JOLLA PHARMACEUTICAL CO | $3,777,000 | +9.3% | 890,700 | 0.0% | 0.13% | +15.3% | |
| TARA | PROTARA THERAPEUTICS INC | $3,293,000 | -35.0% | 209,227 | 0.0% | 0.11% | -31.3% | |
| GNCA | GENOCEA BIOSCIENCES INC | $3,074,000 | +12.0% | 1,134,453 | 0.0% | 0.10% | +18.2% | |
| LSAQ | LIFESCI ACQUISITION II CORP | $2,028,000 | -5.0% | 200,000 | 0.0% | 0.07% | 0.0% | |
| OMEG | New | OMEGA ALPHA SPACcl a | $1,980,000 | – | 200,000 | +100.0% | 0.07% | – |
| CHFWU | CONSONANCE HFW ACQUISITION Cunit 99/99/9999 | $1,952,000 | -6.8% | 200,000 | 0.0% | 0.07% | -1.5% | |
| BOLT | New | BOLT BIOTHERAPEUTICS INC | $1,646,000 | – | 50,000 | +100.0% | 0.06% | – |
| CLRB | CELLECTAR BIOSCIENCES INC | $1,481,000 | -22.6% | 920,000 | 0.0% | 0.05% | -19.4% | |
| NUVBWS | New | NUVATION BIO INCw exp 07/07/202 | $712,000 | – | 266,666 | +100.0% | 0.02% | – |
| ZGNX | ZOGENIX INC | $533,000 | -2.4% | 27,300 | 0.0% | 0.02% | 0.0% | |
| VINC | Exit | VINCERA PHARMA INC | $0 | – | -300,000 | -100.0% | -0.20% | – |
| ARYB | Exit | ARYA SCIENCES ACQUISTION CO | $0 | – | -600,000 | -100.0% | -0.21% | – |
| FSDC | Exit | FS DEV CORP | $0 | – | -700,000 | -100.0% | -0.25% | – |
| PANA | Exit | PANACEA ACQUISITION CORPcl a | $0 | – | -800,000 | -100.0% | -0.30% | – |
| SPPI | Exit | SPECTRUM PHARMACEUTICALS INC | $0 | – | -3,333,333 | -100.0% | -0.36% | – |
| CLDX | Exit | CELLDEX THERAPEUTICS INC NEW | $0 | – | -1,000,000 | -100.0% | -0.56% | – |
| PRVL | Exit | PREVAIL THERAPEUTICS INC | $0 | – | -1,123,105 | -100.0% | -0.83% | – |
| PAND | Exit | PANDION THERAPEUTICS INC | $0 | – | -2,107,513 | -100.0% | -1.01% | – |
| SGEN | Exit | SEATTLE GENETICS INC | $0 | – | -400,000 | -100.0% | -2.25% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-05-17
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MIRATI THERAPEUTICS INC | 32 | Q3 2023 | 55.2% |
| BEIGENE LTD | 31 | Q3 2023 | 15.6% |
| KURA ONCOLOGY INC. | 24 | Q3 2021 | 4.7% |
| ROCKET PHARMACEUTICALS INC | 23 | Q3 2023 | 5.4% |
| DBV TECHNOLOGIES S A | 23 | Q3 2023 | 3.9% |
| MEI PHARMA INC | 21 | Q2 2023 | 1.4% |
| SYNDAX PHARMACEUTICALS INC | 20 | Q3 2021 | 3.1% |
| GOSSAMER BIO INC | 19 | Q3 2023 | 4.7% |
| ODONATE THERAPEUTICS INC | 18 | Q1 2022 | 12.5% |
| ESPERION THERAPEUTICS INC NE | 18 | Q2 2021 | 11.0% |
View Boxer Capital, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| IDEAYA Biosciences, Inc. | February 14, 2023 | 2,202,812 | 4.6% |
| Milestone Pharmaceuticals Inc. | February 14, 2023 | 698,861 | 2.0% |
| SpringWorks Therapeutics, Inc. | September 19, 2022 | 3,421,541 | 5.7% |
| iTeos Therapeutics, Inc. | May 11, 2022 | 2,154,058 | 6.1% |
| Atreca, Inc. | February 14, 2022 | 2,202,333 | 7.2% |
| Biomea Fusion, Inc. | February 14, 2022 | 1,188,405 | 4.1% |
| Cabaletta Bio, Inc. | February 14, 2022 | 540,000 | 1.9% |
| CymaBay Therapeutics, Inc. | February 14, 2022 | ? | ? |
| DBV Technologies S.A. | February 14, 2022 | 1,067,299 | 1.9% |
| Elevation Oncology, Inc. | February 14, 2022 | 872,780 | 3.8% |
View Boxer Capital, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G | 2024-04-22 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G | 2024-02-12 |
| 4 | 2024-02-08 |
| SC 13D/A | 2024-02-08 |
| 4 | 2024-01-25 |
| SC 13D/A | 2024-01-25 |
| SC 13G | 2024-01-18 |
| SC 13D/A | 2023-12-18 |
View Boxer Capital, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.